Literature DB >> 1936128

Mechanisms of the tetrahydroaminoacridine effect on action potential and ion currents in myelinated axons.

F Elinder1, P Arhem.   

Abstract

9-Amino-1,2,3,4-tetrahydroacridine (THA) in the range of 10-300 microM was shown to prolong the action potential in myelinated nerve fibres of Xenopus laevis. Voltage-clamp experiments showed that THA, besides reducing the Na+ and the K+ current, modified the Na+ current inactivation and the K+ current activation. The effects were frequency dependent. Quantitative models were developed and used in computer simulations of the THA effect on the action potential. The computations showed that the observed effects on the ion currents were sufficient to explain the observed prolongation of the action potential. The models further suggest that THA binds to Na+ channels in an open state and from the axoplasmic side while it binds to K+ channels in a closed state. The findings suggest an explanation to some aspects of the clinical effects of THA on Alzheimer patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1936128     DOI: 10.1016/0922-4106(91)90044-i

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Tail currents in the myelinated axon of Xenopus laevis suggest a two-open-state Na channel.

Authors:  F Elinder; P Arhem
Journal:  Biophys J       Date:  1997-07       Impact factor: 4.033

2.  Effects of gadolinium on ion channels in the myelinated axon of Xenopus laevis: four sites of action.

Authors:  F Elinder; P Arhem
Journal:  Biophys J       Date:  1994-07       Impact factor: 4.033

3.  Bupivacaine blocks N-type inactivating Kv channels in the open state: no allosteric effect on inactivation kinetics.

Authors:  Johanna Nilsson; Michael Madeja; Fredrik Elinder; Peter Arhem
Journal:  Biophys J       Date:  2008-09-12       Impact factor: 4.033

Review 4.  Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease.

Authors:  A J Wagstaff; D McTavish
Journal:  Drugs Aging       Date:  1994-06       Impact factor: 3.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.